What is the recommended approach to managing a patient infected with hepatitis C virus who has been on combination interferon and ribavirin therapy and who has developed peripheral neuropathy?
Thirty-three patients with liver cirrhosis were investigated clinically and electrophysiologically. Nerve-conduction abnormalities were present in 24 (73%) patients compared with 71% reported in a ...
"Alterations in axonal membrane and channel function occur early in the disease course, prior to discernable large fibre involvement, and has the potential to be used as an early biomarker of ...
JACKSONVILLE, FLORIDA, UNITED STATES, September 7, 2022 /EINPresswire.com/ -- Bringing awareness to advancements in neuropathy treatment, improving patient outcomes ...
Peripheral neuropathy (PN) is a dose-limiting side effect of chemotherapeutic and antibody drug conjugate (ADC) treatment which significantly impacts patients’ quality of life. Despite a high clinical ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback